首页 › 基金 › NEXTBio Capital Management LP › LBRX
NEXTBio Capital Management LP 对 LBRX 的持仓历史
LB PHARMACEUTICALS INC · 医疗保健
NEXTBio Capital Management LP 在 Q3 2026 的 13F 申报中披露持有 LBRX(LB PHARMACEUTICALS INC)69,549 股,市值约 US$2.7M,约占其申报组合的 1.16%,在其申报持仓中市值排名第 21 位。 NEXTBio Capital Management LP 最近 2 个申报季度中有 2 个季度披露了 LBRX 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
NEXTBio Capital Management LP 对 LBRX 的持仓演变
NEXTBio Capital Management LP 于 Q2 2026 首次披露 LBRX 持仓:68,249 股(约 US$2.2M)。 该持仓在 Q3 2026 达到峰值 69,549 股,市值约 US$2.7M。 在 2 次申报中,NEXTBio Capital Management LP 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 69,549 股、市值约 US$2.7M,环比增持 1,300 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 68.25K | $2.22M | 新进 |
| Q3 2026 | 69.55K | $2.67M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 LBRX 与 13F 数据
LBRX(LB PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 106 只申报持有 LBRX,申报仓位最大的包括:Deep Track Capital, LP (US$108.8M), RA CAPITAL MANAGEMENT, L.P. (US$71.7M), Trails Edge Capital Partners, LP (US$49.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 LBRX 的基金
- Deep Track Capital, LP 3.35M 股 · $108.82M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 2.21M 股 · $71.68M · Q2 2026
- Trails Edge Capital Partners, LP 1.52M 股 · $49.43M · Q2 2026
- Commodore Capital LP 1.50M 股 · $48.68M · Q2 2026
- TCG Crossover Management, LLC 1.45M 股 · $46.97M · Q2 2026
- Caligan Partners LP 1.44M 股 · $46.67M · Q2 2026
- Spruce Street Capital LP 1.38M 股 · $44.66M · Q2 2026
- Nantahala Capital Management, LLC 1.05M 股 · $34.17M · Q2 2026
- Vivo Capital, LLC 800.00K 股 · $30.70M · Q3 2026
- Nan Fung Group Holdings Ltd 630.66K 股 · $20.47M · Q2 2026
- Logos Global Management LP 585.00K 股 · $18.99M · Q2 2026
- GREAT POINT PARTNERS LLC 317.22K 股 · $10.30M · Q2 2026
更多关于 NEXTBio Capital Management LP
常见问题
How long has NEXTBio Capital Management LP held LBRX?
NEXTBio Capital Management LP has disclosed LBRX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is NEXTBio Capital Management LP's current position in LBRX?
As of Q3 2026, NEXTBio Capital Management LP holds 69.55K shares of LBRX (LB PHARMACEUTICALS INC), valued at $2.67M, representing 1.16% of its reported portfolio and ranking #21.
Has NEXTBio Capital Management LP been buying or selling LBRX?
In the latest 13F filing (Q3 2026), NEXTBio Capital Management LP increased its position in LBRX. The position peaked in Q3 2026 at 69.55K shares.
Which other funds hold LBRX?
Other major institutional holders of LBRX include Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., Trails Edge Capital Partners, LP, among 106 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.